Determinants of first-line clinical trial enrollment among Black and Whitegynecologic cancer patients
Few differences in first-line clinical trial enrollment predictors exist between Black and White gynecologic cancer patients. Although small numbers of Black patients and low clinical trial prevalence are limitations, this descriptive analysis is important in understanding racially disparate clinical trial enrollment.
Authors
- Autumn B. Carey
- Ashley Sinclair Felix (ORCID: https://orcid.org/0000-0001-8347-9018)
- Britton Trabert (ORCID: https://orcid.org/0000-0002-1539-6090)
- Casey M. Cosgrove (ORCID: https://orcid.org/0009-0003-1056-9938)
- Caitlin E. Meade (ORCID: https://orcid.org/0009-0005-6417-1399)
Institutions
- University of Utah (US)
- Huntsman Cancer Institute (US)
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Cancer Causes & Control
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1007/s10552-025-01963-y
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00